Literature DB >> 22978806

Benidipine persistently inhibits delayed rectifier K(+)-channel currents in murine thymocytes.

Itsuro Kazama1, Yoshio Maruyama, Mitsunobu Matsubara.   

Abstract

Lymphocytes predominantly express delayed rectifier K(+)-channels (Kv1.3) in their plasma membranes, and the channels play crucial roles in the lymphocyte activation and proliferation. Since 1,4-dihydropyridine (DHP) Ca(2+) channel blockers (CCBs), which are highly lipophilic, exert relatively stronger immunomodulatory effects than the other types of CCBs, they would affect the Kv1.3-channel currents in lymphocytes. In the present study, employing the standard patch-clamp whole-cell recording technique in murine thymocytes, we examined the effects of benidipine, one of the most lipophilic DHPs, on the channel currents and the membrane capacitance and compared them with those of nifedipine. Both drugs significantly suppressed the peak and the pulse-end currents of the channels with significant decreases in the membrane capacitance. However, the effects of benidipine were more marked than those of nifedipine and were irreversible after the drug withdrawal. This study demonstrated for the first time that DHP CCBs, such as nifedipine and benidipine, exert inhibitory effects on thymocyte Kv1.3-channel currents. The persistent effect of benidipine was thought to be associated with its sustained accumulation in the plasma membranes as detected by the long-lasting decrease in the membrane capacitance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22978806     DOI: 10.3109/08923973.2012.723011

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  7 in total

1.  Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.

Authors:  Itsuro Kazama; Tsutomu Tamada; Masahiro Tachi
Journal:  Inflamm Res       Date:  2015-07-24       Impact factor: 4.575

Review 2.  Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.

Authors:  Itsuro Kazama
Journal:  J Physiol Sci       Date:  2014-08-06       Impact factor: 2.781

Review 3.  Roles of lymphocyte kv1.3-channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels.

Authors:  Itsuro Kazama
Journal:  Mediators Inflamm       Date:  2015-03-18       Impact factor: 4.711

4.  Second-Generation Histamine H1 Receptor Antagonists Suppress Delayed Rectifier K+-Channel Currents in Murine Thymocytes.

Authors:  Kazutomo Saito; Nozomu Abe; Hiroaki Toyama; Yutaka Ejima; Masanori Yamauchi; Hajime Mushiake; Itsuro Kazama
Journal:  Biomed Res Int       Date:  2019-04-30       Impact factor: 3.411

Review 5.  Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugs.

Authors:  Itsuro Kazama; Tsutomu Tamada
Journal:  Allergy Asthma Clin Immunol       Date:  2016-11-29       Impact factor: 3.406

6.  Delayed Rectifier K+-Channel Is a Novel Therapeutic Target for Interstitial Renal Fibrosis in Rats with Unilateral Ureteral Obstruction.

Authors:  Nozomu Abe; Hiroaki Toyama; Kazutomo Saito; Yutaka Ejima; Masanori Yamauchi; Hajime Mushiake; Itsuro Kazama
Journal:  Biomed Res Int       Date:  2019-11-07       Impact factor: 3.411

7.  α 1-Adrenergic Receptor Blockade by Prazosin Synergistically Stabilizes Rat Peritoneal Mast Cells.

Authors:  Nozomu Abe; Hiroaki Toyama; Yutaka Ejima; Kazutomo Saito; Tsutomu Tamada; Masanori Yamauchi; Itsuro Kazama
Journal:  Biomed Res Int       Date:  2020-05-12       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.